Local recurrence and survival rates after extended systematic lymph-node dissection for surgical treatment of rectal cancer

被引:1
作者
Hasdemir, O
Çöl, C
Yalçin, E
Tunç, G
Bilgen, K
Kuçukpinar, T
机构
[1] Abant Izzet Baysal Univ, Sch Med, Dept Gen Surg, TR-14280 Bolu, Turkey
[2] SSK Ankara Training & Res Hosp, Surg Dept 1, TR-14280 Bolu, Turkey
关键词
rectal cancer; extended systematic lymphnode dissection; recurrence;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Extended systematic lymphnode dissection (ESLND) is a surgical procedure aimed at decreasing the local recurrence rate of rectal cancer and increasing the survival rate. However, it is criticized because it has not shown the expected effects on survival, and it has been shown to increase the proportion of complications in rectal cancer surgery. This study was designed to determine incidence and patterns of recurrence after curative resection with or without ESLND for rectal cancer. Methodology: A total of 184 patients with rectal cancer were reviewed with respect to surgical procedures, local recurrence and survival rates. Results: 170 of 184 patients with rectal cancer were administered curative surgical resection. ESLND was added to the surgical procedure of 24 of these 170 patients. The local recurrence rate of the patients who did not receive lymph-node dissection was 15%, and the survival rate over 5 years was 58.9%. The local recurrence rate of the patients receiving ESLND was 12.5%, and the survival rate over 5 years was found to be 55.7% (p > 0.05). Conclusions: Because ESLND is a procedure added on to curative resection in the surgical treatment of rectal cancer, it increases the general anesthesia and length of surgery, and it is possible that some complications due to the operation itself may arise. In the current study and in a large amount of research in the literature, a statistically significant effect on the survival rate has not been found. In conclusion, the opinion has been reached that ESLND does hot have an important benefit in the curative surgical treatment of rectal cancer.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 50 条
  • [31] Optimal Size Criteria for Lateral Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Rectal Cancer
    Kawai, Kazushige
    Shiratori, Hiroshi
    Hata, Keisuke
    Nozawa, Hiroaki
    Tanaka, Toshiaki
    Nishikawa, Takeshi
    Murono, Koji
    Ishihara, Soichiro
    DISEASES OF THE COLON & RECTUM, 2021, 64 (03) : 274 - 283
  • [32] Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: a Western perspective
    Peacock, O.
    Limvorapitak, T.
    Bednarski, B. K.
    Kaur, H.
    Taggart, M. W.
    Dasari, A.
    Holliday, E. B.
    Minsky, B. D.
    You, Y. N.
    Chang, G. J.
    COLORECTAL DISEASE, 2020, 22 (12) : 2049 - 2056
  • [33] Lateral Lymph-node Dissection for Rectal Cancer: Meta-analysis of all 944 Cases Undergoing Surgery During 1975-2004
    Kinugasa, Tetsushi
    Akagi, Yoshito
    Ochi, Takafumi
    Ishibashi, Yoshiaki
    Tanaka, Natsuki
    Oka, Yousuke
    Mizobe, Tomoaki
    Yuge, Koutarou
    Fujino, Shinya
    Kibe, Shirou
    Shirouzu, Kazuo
    ANTICANCER RESEARCH, 2013, 33 (07) : 2921 - 2927
  • [34] Incidence of and risk factors for lymphocele formation after lateral pelvic lymph node dissection for rectal cancer: a retrospective study
    Ochiai, K.
    Kaneko, M.
    Nozawa, H.
    Kawai, K.
    Hata, K.
    Tanaka, T.
    Nishikawa, T.
    Shuno, Y.
    Sasaki, K.
    Hiyoshi, M.
    Emoto, S.
    Murono, K.
    Sonoda, H.
    Ishihara, S.
    COLORECTAL DISEASE, 2020, 22 (02) : 161 - 169
  • [35] Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy
    Ogura, Atsushi
    Akiyoshi, Takashi
    Nagasaki, Toshiya
    Konishi, Tsuyoshi
    Fujimoto, Yoshiya
    Nagayama, Satoshi
    Fukunaga, Yosuke
    Ueno, Masashi
    Kuroyanagi, Hiroya
    WORLD JOURNAL OF SURGERY, 2017, 41 (03) : 868 - 875
  • [36] Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy
    Atsushi Ogura
    Takashi Akiyoshi
    Toshiya Nagasaki
    Tsuyoshi Konishi
    Yoshiya Fujimoto
    Satoshi Nagayama
    Yosuke Fukunaga
    Masashi Ueno
    Hiroya Kuroyanagi
    World Journal of Surgery, 2017, 41 : 868 - 875
  • [37] The value of lymph node ratio in the prediction of rectal cancer patient survival after preoperative chemoradiotherapy
    Chen, Li
    Huang, Xuefeng
    Song, Zhangfa
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (12): : 5992 - 6001
  • [38] Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: Mutually exclusive or mutually beneficial?
    Sammour, Tarik
    Chang, George J.
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2018, 2 (05): : 348 - 350
  • [39] Lateral Lymph Node Dissection Was Unnecessary for Low and Middle Rectal Cancer: a Systematic Review and Meta-analysis
    Jiajie Zhou
    Xiaoming Yuan
    Indian Journal of Surgery, 2023, 85 : 1050 - 1064
  • [40] The efficacy and safety of lateral lymph node dissection for patients with rectal cancer: A systematic review and meta-analysis
    Ma, Peilan
    Yuan, Yuan
    Yan, Peijing
    Chen, Guohua
    Ma, Shixun
    Niu, Xiangdong
    Xu, Meng
    Yang, Kehu
    Cai, Hui
    ASIAN JOURNAL OF SURGERY, 2020, 43 (09) : 891 - 901